Transform your biotech and medtech company | KPMG | BE

Transform your biotech and medtech company for a stronger future

Transform your biotech and medtech company

Transform your start-up into the next unicorn.

Transform your start-up into the next unicorn.

Developing a new business idea or seeding your business? KPMG can aid with your assessment of the therapeutic area or the market potential for your new drug, innovative medical device or health app.

For companies who are looking to establish and build their business, KPMG can assist in:

  • identifying a portfolio of options and partners to co-develop a new drug or medical technology
  • executing an alliance strategy
  • protecting your IP and assets from cyber threats
  • maximizing R&D tax benefits

 

We also help you expand and broaden your horizon to achieve your next stage of growth:

  • build up your development excellence capabilities and ensure resources are optimally focused on the right assets in your portfolio
  • support the search for funding to pursue clinical development, expand your discovery portfolio and/or to go public
  • professionalize your support functions, from HR to Procurement and IT
  • co-develop your go-to-market strategy and sales operations to start
  • promoting or co-promoting a successful Phase III drug
  • pro-actively manage new internal and external risks

 

Finally, KPMG assists companies looking for a profitable exit with defining your exit strategy, identifying options and potential partners.
 

Contact

Connect with us

 

Request for proposal

 

Submit